Bone loss breakthrough? drug and exercise combo tested in menopause
NCT ID NCT06789900
First seen Apr 12, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This study tests if a weekly low dose of the drug everolimus, exercise, or both can prevent bone loss in healthy women going through menopause. 136 women aged 45-60 will take part for 24 weeks. The goal is to find a safe way to keep bones strong without hormone therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Odense University Hospital
Odense, 5000, Denmark
Conditions
Explore the condition pages connected to this study.